Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.560
-0.040 (-1.54%)
At close: Jun 27, 2025, 4:00 PM
2.600
+0.040 (1.56%)
After-hours: Jun 27, 2025, 7:53 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Antibody-Based Therapeutics
850.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
850.00K